Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-014783
Filing Date
2016-03-15
Accepted
2016-03-15 08:30:20
Documents
7
Period of Report
2016-04-27
Effectiveness Date
2016-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20160427.htm DEF 14A 1237798
2 GRAPHIC g2016031422533424412923.jpg GRAPHIC 39960
3 GRAPHIC g2016031422533361912921.jpg GRAPHIC 2754
4 GRAPHIC g2016031422532704012919.jpg GRAPHIC 2530
5 GRAPHIC g2016031422532696212918.jpg GRAPHIC 4419
6 GRAPHIC g2016031422533421312922.jpg GRAPHIC 51937
7 GRAPHIC g2016031422532708712920.jpg GRAPHIC 4489
  Complete submission text file 0001564590-16-014783.txt   1385965
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 161505620
SIC: 2834 Pharmaceutical Preparations